-transparent.png){kind=logo}
Spurious methotrexate (MTX) concentrations in sera and cerebrospinal fluids from leukemia patients who were given trimethoprim (TMP) were estimated using an MTX assay kit which is based on its inhibition of dihydrofolate reductase. The interference of TMP with MTX was confirmed in the assay system. A concentration of 0.17 microgram/ml of TMP gave a value for an apparent MTX of 10 microM.
Related Publications
S Kitaoka, and
M Terasawa, and
E Goto, and
T Miyaji, and
S Tsuchiya, and
T Konno
September 1980,
Clinical chemistry,
S Kitaoka, and
M Terasawa, and
E Goto, and
T Miyaji, and
S Tsuchiya, and
T Konno
September 1988,
Annals of clinical biochemistry,
S Kitaoka, and
M Terasawa, and
E Goto, and
T Miyaji, and
S Tsuchiya, and
T Konno
September 1986,
Journal of pharmacological methods,
S Kitaoka, and
M Terasawa, and
E Goto, and
T Miyaji, and
S Tsuchiya, and
T Konno
January 2024,
Methods in molecular biology (Clifton, N.J.),
S Kitaoka, and
M Terasawa, and
E Goto, and
T Miyaji, and
S Tsuchiya, and
T Konno
October 1980,
Clinical chemistry,
S Kitaoka, and
M Terasawa, and
E Goto, and
T Miyaji, and
S Tsuchiya, and
T Konno
March 1981,
Clinical chemistry,
S Kitaoka, and
M Terasawa, and
E Goto, and
T Miyaji, and
S Tsuchiya, and
T Konno
May 1993,
Clinical chemistry,
S Kitaoka, and
M Terasawa, and
E Goto, and
T Miyaji, and
S Tsuchiya, and
T Konno
May 1980,
Clinical chemistry,
S Kitaoka, and
M Terasawa, and
E Goto, and
T Miyaji, and
S Tsuchiya, and
T Konno
January 2006,
Journal of AOAC International,
S Kitaoka, and
M Terasawa, and
E Goto, and
T Miyaji, and
S Tsuchiya, and
T Konno
November 1985,
Annals of clinical biochemistry,
